Lund University Diabetes Centre LUDC

Hem
Sverige
Malmö
Lund University Diabetes Centre LUDC

News from Lund University Diabetes Centre At LUDC, more than 300 people work in a vibrant research environment consisting of more than 30 research groups.

Lund University Diabetes Centre (LUDC) is a research centre dedicated to unravelling the mechanisms behind diabetes and its complications. Our vision at LUDC is to improve patient stratification and to undertake innovative translational studies that lead to better prevention and management of diabetes and its complications through precision diabetes medicine. Our scientists work within the Lund Un

iversity strategic research area EXODIAB (Excellence of Diabetes Research in Sweden). EXODIAB is a joint strategic diabetes research initiative at Lund University and Uppsala University. Within the framework of EXODIAB, our scientists look for new treatments and drugs to prevent, delay, or cure diabetes. The research teams also work towards developing personalised care and treatment for patients with diabetes. Various fields of research are integrated within clinical studies and population studies (epidemiology), and platforms for collaboration between academia and industry are created. On our page, you can take part in, comment on and discuss current research and events at LUDC. You are welcome to comment on our posts and publish content on our site, but avoid the following:
– offensive language
– defamation, threats or personal attacks
– incitement to racial hatred, harassment or sexual harassment
– spam and irrelevant advertising
– offensive personal data
– illegal material
– copyrighted material published without permission

All comments are reviewed and material that does not follow the guidelines above and/or violates Swedish law will be removed if necessary. All posts on the page are public documents and may be registered. Please visit the LUDC website for more information about LUDC:
https://www.ludc.lu.se/

17/06/2026

🔬 Register for LUDC’s Anniversary Symposium by June 26 🔬

You can still register for Lund University Diabetes Centre's 20th Anniversary Symposium – Evolving heterogeneity in diabetes. Join our celebration in Malmö on September 24-25 🎉

To celebrate the 20th anniversary, we are inviting some of the world's most distinguished diabetes researchers to Malmö to discuss new developments and research questions. This two-day symposium will not just look back at the last 20 years but also discuss the future of diabetes research.

Read more: https://www.ludc.lu.se/ludc-20th-anniversary-symposium

Register here: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=lICmegRhpkG0Q9S1JFH2F76ASMouxepEnQcH2PrtmzJUOEpWMlRLWUZNUUNJQ0hKRzg1NktZN041MC4u

Event details:
📅 Date: September 24-25
📍 Place: Jubileumsaulan, Jan Waldenströms gata 1, Skånes universitetssjukhus (Skåne University Hospital), Malmö, Sweden
✅ Register by June 26

📢 Confirmed speakers:
Jens Juul Holst, Helena Elding Larsson, Anette-Gabriele Ziegler, Chantal Mathieu, Christopher Bang Newgard, Jens Lagerstedt, Elisa De Franco, Anna Gloyn, Patrik Rorsman, Paul Franks, Sonia García Calzón, Ewan Pearson, Emma Ahlqvist, Stefano Romeo, Hiddo Lambers Heerspink, Jan Nilsson, and Peter Rossing

🔹 Welcome talk by Erik Renström, Vice-Chancellor, Lund University, and concluding remarks by Allan Vaag and Lena Eliasson, Coordinators of LUDC

📷 Photograph by Kennet Ruona

08/06/2026

Paul Franks, professor of genetic epidemiology at Lund University Diabetes Centre, is leading two new commissions on obesity-related diseases and precision health. The aim with precision medicine is to develop individualised treatment of, for example, diabetes.

In May, the journal Nature Medicine launched a commission on obesity that aims to address the gaps in obesity management. Obesity is associated with type 2 diabetes and many other diseases.

“Success will mean creating tools and evidence that objectively improve how obesity is managed across different populations, settings, and scenarios. This is a long-term effort with the potential for transformative global impact” says Paul Franks, leader of the new commission.

He is also the leader of a new commission on precision health which will examine how precision approaches can improve healthcare effectiveness, cost-efficiency, equity, and scalability across resource settings and global regions. The journal The Lancet started the commission, which may contribute to better treatment of different diseases, including diabetes.

Read about Nature Medicine's commission on obesity: https://www.ludc.lu.se/article/lund-university-professor-leads-nature-medicine-commission-data-driven-obesity-management

Read about The Lancet's commission on precision medicine: https://www.ludc.lu.se/article/lund-university-professor-leads-lancet-commission-precision-medicine

Links to the websites of the two commissions:
https://www.theobesitycommission.org/
https://www.theprecisionhealthcommission.org/

Nature Medicine The Lancet

04/06/2026

Our network of early career researchers is arranging today’s LUDC ECN Methodology Day at Faculty of Medicine Malmö. Today’s event brings together a set of talks focused on how to generate, analyse, and interpret data in diabetes research 🔬

Leonie Mieke Engelhard, Sweta Raikundalia, and Abrar Ahmad from the LUDC Early Career Network have all been involved in the planning activities of today’s event. During the event, researchers and postdoctoral students at different stages of their careers are invited to share experiences.

Lucas Maurin, postdoctoral fellow from the LUDC research group Diabetes – Epigenetics, is one of today's speakers. His presentation about data visualisation in the programming language R offers new insights into how life scientists can use R to generate quality graphics for research communication.

Read about the programme: https://www.ludc.lu.se/calendar/ludc-ecn-methodology-day-2026

22/05/2026

Patrick MacDonald, professor at University of Alberta and visiting professor at the Faculty of Medicine at Lund University, will be one of the speakers during the LUDC ECN Methodology Day in Malmö on June 4.

🔬The LUDC ECN Methodology Day is a half day seminar with talks focused on research methods, arranged by LUDC ECN, our network of early career researchers at Lund University Diabetes Centre.

Patrick MacDonald will give an overview of human islet isolation, phenotyping, and web tools for data access and analysis. We hope that his insights will give researchers new ideas on how to explore complex datasets.

Join the LUDC ECN Methodology Day for talks on biomedical research, gene editing, stem cell models, advanced data visualisation, and statistical interpretation. The event is aimed at young scientist, postdoctoral fellows, and students at LUDC.

Read more and register: https://www.ludc.lu.se/calendar/ludc-ecn-methodology-day-2026

Medicinska fakulteten vid Lunds universitet

📷 Photograph by Ingemar Hultquist

19/05/2026

Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and AstraZeneca show that integrating measurements such as body fat percentage and waist circumference captures disease risks missed by BMI alone.

“Our analyses show that combining body fat percentage and waist circumference when screening for obesity can help us identify individuals at high risk of developing obesity-related diseases that may be missed by using BMI alone,” says Sophie Gunnarsson, one of the leading authors of a new study, published in eBioMedicine.

Sophie Gunnarsson, employed by AstraZeneca and an industrial PhD student at Lund University Diabetes Centre, is developing her research within the DDLS programme, the SciLifeLab and Wallenberg national programme for data-driven life science. Rashmi Prasad, associate professor of genetics and diabetes at Lund University, is the main academic supervisor of the project.

“I think that our new study is a fantastic example of how researchers in academia and industry can collaborate and hopefully contribute with new knowledge that may help identify individuals who are at elevated risk of obesity-related diseases,” says Rashmi Prasad.

Read more: https://www.ludc.lu.se/article/new-study-bmi-alone-does-not-fully-capture-health-risks-linked-obesity

📷 Photograph of Rashmi Prasad and Sophie Gunnarsson

SciLifeLab (Science for Life Laboratory) Lund University

27/04/2026

Researchers at Lund University Diabetes Centre have carried out the most detailed mapping to date of the epigenome in the cells that regulate the body’s blood sugar levels. The study, published in Nature Metabolism, shows how chemical changes to DNA affect both insulin-producing cells and glucagon-producing alpha cells and how these patterns change in type 2 diabetes 🧬

Long term, the knowledge can be used to identify new, personalised treatment targets. Charlotte Ling, Jones Ofori, Sabrina Ruhrmann, and Karl Bacos, researchers at LUDC and the strategic research area EXODIAB, have all made significant contributions to the study.

Read more: https://www.ludc.lu.se/article/new-research-shows-how-blood-sugar-regulating-cells-change-type-2-diabetes

📷 Photograph of Charlotte Ling, Jones Ofori, Sabrina Ruhrmann and Karl Bacos

07/04/2026

A growing body of research shows that diabetes can be stratified into five different subgroups. LUDC researchers have now investigated whether a person’s genetic predisposition to different diabetes subgroups can help assess the risk of developing coronary artery disease ❤️‍🩹

The team created genetic risk scores and found that the scores for one subgroup could predict coronary artery disease, even before onset of diabetes.

“I hope that genetic risk scores can be used to identify individuals who are at risk of developing diabetes and coronary artery disease long before early signs of disease. This would give us a better opportunity to delay or prevent onset of the disease,” says Andreas Edsfeldt, associate professor in cardiology at Lund University Diabetes Centre and cardiologist at Skåne University Hospital in Malmö.

The new article in Diabetes Care is part of a thesis project by Mengyu Pan, one of the co-authors. Her supervisors Andreas Edsfeldt and Jiangming Sun have led the new study.

Read more: https://www.ludc.lu.se/article/researchers-predict-coronary-heart-disease-diabetes-subgroup

📷 Photograph of Jiangming Sun, Mengyu Pan, and Andreas Edsfeldt

01/04/2026

We would like to extend our warmest congratulations to Professor Charlotte Ling at Lund University who receives the Novo Nordisk Foundation Nordic Diabetes Prize 2026 🌟 👏

Charlotte Ling is research group leader of Diabetes – Epigenetics at Lund University Diabetes Centre and has led several important discoveries within epigenetics and diabetes.

Studies by Charlotte Ling and the research group have revealed how lifestyle and environmental factors such as diet, exercise, age, and obesity alter gene activity in organs and tissues, which may cause type 2 diabetes. The research group is also developing blood-based epigenetic biomarkers which predict treatment response in individuals with type 2 diabetes.

The Novo Nordisk Foundation Nordic Diabetes Prize is accompanied by DKK 500,000 for research and a personal award of DKK 100,000. As the 2026 prize recipient, Charlotte Ling will give a lecture at the SSSD annual meeting in Gävle, Sweden, in May.

Read more:
https://novonordiskfonden.dk/en/news/leading-researcher-honoured-with-nordic-prize-for-uncovering-how-gene-activity-drives-type-2-diabetes/

Register for SSSD's annual meeting: https://www.sssd2026.se/

Novo Nordisk Foundation Medicinska fakulteten vid Lunds universitet

📷 Photograph of Charlotte Ling by Kennet Ruona

31/03/2026

🧫 LUDC’s 20th Anniversary Symposium – Evolving heterogeneity in diabetes – September 24-25 🔬

Since Lund University Diabetes Centre was formed 20 years ago, the centre has been committed to improving the quality of life for people with diabetes. To celebrate the anniversary, we are inviting you and some of the world's most distinguished diabetes researchers to Malmö to discuss the future of diabetes research 💙

Event details:
📅 Date: September 24- 25
📍Place: Jubileumsaulan, Jan Waldenströms gata 1, Skånes universitetssjukhus (Skåne University Hospital), Malmö, Sweden
✅ Register by June 26

🔗 Read about the programme: https://www.ludc.lu.se/ludc-20th-anniversary-symposium

🔗 Register via the link: https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=lICmegRhpkG0Q9S1JFH2F76ASMouxepEnQcH2PrtmzJUOEpWMlRLWUZNUUNJQ0hKRzg1NktZN041MC4u

📷 Photograph by Kennet Ruona of research nurse and participant from the TEDDY study

Lund University Medicinska fakulteten vid Lunds universitet

26/03/2026

Our warmest congratulations to LUDC researcher Anna Stubbendorff who is this year’s recipient of the Lund University Agenda 2030 Graduate School Award for Sustainability! 🌍 🏆

Anna Stubbendorff is affiliated with the strategic research area EXODIAB at Lund University and presented her thesis project earlier this year. She receives the award for research on how diets with lower environmental impact relate to nutritional adequacy, cardiometabolic disease risk, and mortality.

The award will be presented at an award ceremony during the Sustainability Week in Lund, when Anna Stubbendorff will give a presentation.

A study by Anna Stubbendorff was recently published in the Lancet Planetary Health and showed that the nutrient intake among those who ate an environmentally sustainable diet was comparable to those who had a diet with more animal products.

Read about the award: https://www.agenda2030graduateschool.lu.se/activities/lund-university-agenda-2030-award-winner-and-honourable-mentions/agenda-2030-award-goes-anna-stubbendorff-her-research-sustainable-diets

Read about the new study in the Lancet Planetary Health: https://www.ludc.lu.se/article/climate-friendly-diet-yielded-unexpectedly-strong-nutritional-outcomes

📷 Photograph by Adam Haglund

Adress

Jan Waldenströms Gata 35
Malmö
21428

Webbplats

http://www.ludc.lu.se/

Aviseringar

Var den första att veta och låt oss skicka ett mail när Lund University Diabetes Centre LUDC postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Genvägar

Vill du placera din affär längst upp i Hälso- Och Skönhetsföretag-listan i Malmö?

Dela

Typ

Medicin och hälsa